About Nikolai Pharmaceuticals Private Limited
Data last updated:
Nikolai Pharmaceuticals Private Limited is a private limited company based in Nagpur, Maharashtra, India. It was incorporated on 21 June 2024.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U46497MH2024PTC427447.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Nidhi Goyal and Amit Goyal.
Its last annual general meeting (AGM) was held on 22 October 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Nagpur, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹7.12 Lakh. For the same year it recorded a net loss of ₹2.78 Lakh (net margin -39%) and EBITDA of -₹2.34 Lakh (EBITDA margin -32.8%).
For more details, the company can be reached via its website nikolaipharmaceuticals.in.
Company details
Contact details
Nikolai Pharmaceuticals Private Limited's registered office is in Nagpur, Maharashtra.
- Registered AddressPlot No 1150/17, Harsha Coperative Society, Nagpur, Maharashtra, India – 440023
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Nikolai Pharmaceuticals Private Limited
FY 2025 filings availableNikolai Pharmaceuticals Private Limited reported revenue of ₹7.12 Lakh for FY 2025.
Financial Statement Summary
| Metrics | FY 2024-25 |
|---|---|
| Profit and Loss Statement | |
| Revenue from Operations | |
| Other Income | |
| Total Revenue | |
| Cost of Materials Consumed | |
| Employee Benefit Expense | |
| Finance Costs | |
| Depreciation and Amortisation | |
| Other Expenses | |
| Total Expenses | |
| EBITDA | -₹2.34 Lakh |
| Profit Before Tax | |
| Tax Expense | |
| Net Profit (PAT) | -₹2.78 Lakh |
| Balance Sheet | |
| Share Capital | |
| Reserves and Surplus | |
| Net Worth (Total Equity) | |
| Long-term Borrowings | |
| Short-term Borrowings | |
| Trade Payables | |
| Total Liabilities | |
| Fixed Assets | |
| Investments | |
| Inventories | |
| Trade Receivables | |
| Cash and Bank Balance | |
| Total Assets | |
Financial Ratios
| Metrics | FY 2024-25 |
|---|---|
| Profitability | |
| EBITDA Margin | -32.8% |
| Net Profit Margin | -39% |
| Return on Equity (ROE) | |
| Return on Capital Employed (ROCE) | |
| Return on Assets (ROA) | |
| Liquidity and Debt | |
| Current Ratio | |
| Quick Ratio | |
| Debt-to-Equity Ratio | |
| Interest Coverage Ratio | |
| Efficiency and Growth | |
| Asset Turnover | |
| Receivable Days | |
| Payable Days | |
| Inventory Days | |
| Revenue Growth | |
| Net Profit Growth | |
To see the full financial statements and ratios of Nikolai Pharmaceuticals Private Limited, buy the company report.
Board of directors of Nikolai Pharmaceuticals Private Limited
Nikolai Pharmaceuticals has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Nidhi Goyal | Director | 21 Jun 2024 | 2 Years 4 Months | Current |
| Amit Goyal | Director | 21 Jun 2024 | 2 Years 4 Months | Current |
Peer comparison
Nikolai Pharmaceuticals Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Sunbow Pharmaceuticals Private Limited | ₹7.21 Lakh (FY 2025) | -37.0% | Guwahati, Assam, India | |||
| Promediate Pharmaceuticals Private Limited | ₹7.2 Lakh (FY 2025) | -30.0% | Aurangabad, Maharashtra, India | |||
| Sharman Pharmaceuticals Private Limited | ₹7.17 Lakh (FY 2023) | Mumbai, Maharashtra, India | ||||
| VSR Pharmaceuticals Private Limited | ₹7.16 Lakh (FY 2021) | 93.0% | Hyderabad, Telangana, India | |||
| Vixen Pharmaceuticals Private Limited | ₹7.13 Lakh (FY 2020) | 32.0% | Kaithal, Haryana, India | |||
| Nikolai Pharmaceuticals Private Limitedthis company | ₹7.12 Lakh (FY 2025) | -₹2.78 Lakh | -39% | Nagpur, Maharashtra, India | ||
| Skele Pharmaceuticals Private Limited | ₹7.12 Lakh (FY 2023) | Lucknow, Uttar Pradesh, India | ||||
| Tonemax Pharmaceuticals Private Limited | ₹7.11 Lakh (FY 2024) | 1626.0% | Bangalore, Karnataka, India | |||
| Gundicha Pharmaceuticals Private Limited | ₹7.09 Lakh (FY 2020) | -7.0% | Mumbai, Maharashtra, India | |||
| Lionise Pharmaceuticals Private Limited | ₹7.09 Lakh (FY 2021) | 450.0% | New Delhi, Delhi, India | |||
| Welsave Pharmaceuticals Private Limited | ₹7.07 Lakh (FY 2025) | 70.0% | Delhi, India |
To see the full peer comparison of Nikolai Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Nikolai Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Nikolai Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Nikolai Pharmaceuticals Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Nikolai Pharmaceuticals Private Limited has 2 board changes on record since 2024: 2 appointments. The latest: Amit Goyal was appointed as Director on 21 Jun 2024.
Frequently asked questions
Nikolai Pharmaceuticals is an active private limited company based in Nagpur, Maharashtra, India. It was incorporated on 21 June 2024 (2+ years old) and is registered under CIN U46497MH2024PTC427447.
Nikolai Pharmaceuticals has 2 current directors:
- Nidhi Goyal - Director
- Amit Goyal - Director
The latest financial statements of Nikolai Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 22 October 2025. Year-wise statements from FY 2025 are in the company report.
The CIN (Corporate Identification Number) of Nikolai Pharmaceuticals is U46497MH2024PTC427447. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Nikolai Pharmaceuticals was incorporated on 21 June 2024, making it 2+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Nikolai Pharmaceuticals by revenue are Sunbow Pharmaceuticals Private Limited, Promediate Pharmaceuticals Private Limited, Sharman Pharmaceuticals Private Limited, VSR Pharmaceuticals Private Limited, Vixen Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharmaceuticals).
Amit Goyal was appointed as Director on 21 Jun 2024. Nidhi Goyal was appointed as Director on 21 Jun 2024.
Nikolai Pharmaceuticals can be reached through the website nikolaipharmaceuticals.in. Its registered office is in Nagpur, Maharashtra, India.
The registered office of Nikolai Pharmaceuticals is at Plot No 115017, Harsha Coperative Society, Nagpur, Maharashtra, India – 440023.
Nikolai Pharmaceuticals is registered under the jurisdiction of the Registrar of Companies (ROC), Mumbai.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
